Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
OBJECTIVE— Fibroblast growth factor 21 (FGF21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and insulin sensitivity in animal models. This study aimed to investigate the relationship between its serum levels and various cardiometabolic parameters in humans. RESEAR...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | engelsk |
Udgivet: |
2008
|
Online adgang: | https://doi.org/10.2337/db07-1476 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|